Dose-dependent urinary retention following olanzapine administration [2]

Annals of Pharmacotherapy

Volumn 40, Issue 9, 2006, Pages 1693-

  Semaan, William E ^a   Doyon, Julie ^a   Jolicœur, François ^a   Duchesneau, Joseé ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; CREATININE; ELECTROLYTE; HALOPERIDOL; LORAZEPAM; OLANZAPINE; UREA;

ADULT; AGITATION; ALCOHOL CONSUMPTION; ANTICHOLINERGIC EFFECT; AUDITORY HALLUCINATION; BLOOD CELL COUNT; CASE REPORT; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE REDUCTION; HALLUCINATION; HUMAN; LETTER; MALE; PARANOID PSYCHOSIS; PARANOID SCHIZOPHRENIA; PERSECUTORY DELUSION; PRIORITY JOURNAL; PROBABILITY; TREATMENT OUTCOME; URINALYSIS; URINE CULTURE; URINE RETENTION;

ADULT; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; URINARY RETENTION;

EID: 33748302933     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G697     Document Type: Letter

References (4)

1. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill, 1996:399-459.
2. Sokolski KN, Brown BJ, Melden M. Urinary retention following repeated high-dose quetiapine (letter). Ann Pharmacother 2004;38:899-900. DOI 10.1345/aph.1D502
3. Bezchlibnyk-Butler KZ, Jeffries JJ, eds. Clinical handbook of psychotropic drugs. 15th ed. Toronto: Hogrefe & Huber Publishers, 2005:105.
4. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.